Supplementary Material for Perkin Transactions 2
This journal is © The Royal Society of Chemistry 2002
Dioxaphosphepine examples | ||
---|---|---|
BIQTAW | HATHIT | HEKPES |
Dioxaphosphepine examples | ||
JOWFAC | LODHOB | OXPCTP10 |
Diazaphosphepine example | ||
WEMTAJ | ||
Dioxaphosphole and Diazaphosphole example | ||
DOFSUM | YUJFOV | |
Triarsenoazobenzene example | ||
HPTARZ | ||
Calculated energies (hartree) and NICS values (ppm) for 5–10 | |||||
---|---|---|---|---|---|
Substituents | Energy | NICSa | Substituents | Energy | NICSa |
5, X = O, R = H | −1493.59245 | 1.0 (−2.2)/−0.4 | 5, X = NH, R = H | −1453.84743 |
1.9 (−1.8)/−0.3 |
5, X = O, R = benzo | −1800.91060 | 1.5 (−1.7)/1.2 | |||
5, X = O, R = F | −1890.49767b | 0.9 (−2.3)/−5.0 | 5, X = NF, R = F | −2049.05166 (2.8)c |
1.5 (−2.0)/−9.6 |
6, X = O, R = F | −1237.02783b | −7.9 (−7.7)/−5.9 | 6, X = N, R = F | −1395.58808 (7.0)c |
−7.7(−7.6)/−11.6 |
6, X = S, R = F | −1882.94836 | −5.3 (−5.6)/−9.5 | |||
6, X = O, R = F, Asd | −3129.40995 | −7.6 (−8.0)/−7.8 | 6, X = NF, R = F, Asd | −3287.97290 | −7.3 (−7.8)/−12.2 |
7, X = O, R = F | −1614.62798 |
0.3 (−2.8)/−7.8 | 7, X = NF, R = F |
−1773.19255 (5.2)e |
2.4/−9.2 |
8, X = O, R = F | −961.16074 |
−8.8 (−8.6)/−7.1 | 8, X = NF, R = F |
−1119.72821 (4.0)e |
−7.7 (−7.5)/−9.2 |
9, X = O, R = F | −1494.32476 |
−0.9 (0.2)/−4.5 | 9, X = NF, R = F |
−1652.88226 |
0.4 (0.6)/−8.6 |
10, X = O, R = F, R' = H | −1159.51846 |
2.6/−4.8 |
10, X = NF, R = F, R' = H |
−1318.07670 |
5.2/−8.3 |
10, X = O, R = F, R' = F | −1457.18499 | −17.2/−4.6 | 10, X = NF, R = F, R' = F |
1615.74390 (1.3)f |
−16.2/−8.3 |
aNICS(0) value at ring B centroid (NICS(1) value 1 Å above ring B centroid)/NICS(0) value at ring A centroid. bGeometry optimisation converges to C2 symmetric conformation. cRelative energy (kcal mol−1) Cs symmetric conformation. dAs replacing P. eRelative energy (kcal mol−1) of anti-conformation, with no symmetry. fRelative energy (kcal mol−1) of chiral diastereoisomer.